Modern Diagnostic & Research Centre Key Ratios
BSE: 544673
₹48.51
₹-0.24
(-0.49%)
As on 02-Sep-2026 16:01IST
Market cap
₹77 Cr
Revenue (TTM)
₹78 Cr
P/E Ratio
14.6
P/B Ratio
1.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 16.11 | 8.99 | -- |
| EBIT | -- | -- | 93.20 | 80.76 | -- |
| Net Profit | -- | -- | 54.76 | 101.48 | -- |
| EPS | -- | -- | 54.76 | 101.48 | -- |
| Book Value | -- | -- | 76.27 | 21.01 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 6.55 | -- | 17.67 | 10.62 | -8.63 |
| Net Margin
| 3.23 | -- | 11.38 | 8.44 | -10.13 |
| Return on equity
| 18.56 | -- | 55.21 | 65.40 | -64.92 |
| Return on Capital
| 18.15 | -- | 39.00 | 32.42 | -16.98 |
| Return on Assets
| 5.25 | -- | 15.73 | 13.47 | -13.45 |
| Debt to Equity (x)
| -- | -- | 1.07 | 1.74 | 2.57 |
Profitability
ROCE
39.00
Higher than Peers by 18.74
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
39.00
|
32.42
|
-16.98
|
8.43
|
--
|
|
Peer Median
|
20.26
|
19.83
|
33.53
|
37.00
|
--
|
ROE
55.21
Higher than Peers by 41.29
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
55.21
|
65.40
|
-64.92
|
-12.41
|
--
|
|
Peer Median
|
13.93
|
15.80
|
26.65
|
26.85
|
--
|
ROA
15.73
Higher than Peers by 5.73
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
15.73
|
13.47
|
-13.45
|
-2.98
|
--
|
|
Peer Median
|
10.00
|
8.30
|
16.54
|
17.58
|
--
|
EBIT Margin
17.67
Lower than Peers by 1.99
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
17.67
|
10.62
|
-8.63
|
3.87
|
--
|
|
Peer Median
|
19.66
|
18.70
|
19.68
|
25.18
|
--
|
Net Margin
11.38
Lower than Peers by 0.58
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
11.38
|
8.44
|
-10.13
|
-2.40
|
--
|
|
Peer Median
|
11.96
|
12.26
|
16.78
|
18.16
|
--
|
Cash Profit Margin
16.88
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
16.88
|
14.48
|
-3.31
|
3.67
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
16.11
Higher than Peers by 0.37
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
16.11
|
19.28
|
-6.52
|
--
|
--
|
|
Peer Median
|
15.74
|
13.67
|
4.18
|
49.99
|
--
|
EBIT Growth
93.20
Higher than Peers by 70.60
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
93.20
|
246.84
|
-308.19
|
--
|
--
|
|
Peer Median
|
22.60
|
11.16
|
-14.65
|
108.09
|
--
|
Net Profit Growth
54.76
Higher than Peers by 31.47
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
54.76
|
201.10
|
-294.93
|
--
|
--
|
|
Peer Median
|
23.29
|
9.39
|
-16.12
|
151.45
|
--
|
EPS Growth
54.76
Higher than Peers by 25.33
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
54.76
|
201.10
|
-294.93
|
--
|
--
|
|
Peer Median
|
29.43
|
-7.32
|
-35.05
|
150.72
|
--
|
Book Value Growth
76.27
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
76.27
|
97.18
|
-49.01
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.07
Higher than Peers by 1.02
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
1.07
|
1.74
|
2.57
|
1.74
|
--
|
|
Peer Median
|
0.05
|
0.08
|
0.15
|
0.03
|
--
|
Short term debt to equity ratio
0.45
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
0.45
|
0.63
|
1.17
|
0.43
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.75
Lower than Peers by 1.68
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
0.75
|
0.75
|
0.58
|
0.87
|
--
|
|
Peer Median
|
2.42
|
2.28
|
1.88
|
2.40
|
--
|
Quick Ratio
0.59
Lower than Peers by 1.78
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
0.59
|
0.63
|
0.49
|
0.80
|
--
|
|
Peer Median
|
2.37
|
2.33
|
1.78
|
3.09
|
--
|
Interest Coverage
7.67
Higher than Peers by 0.05
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
7.67
|
4.80
|
-3.21
|
1.73
|
--
|
|
Peer Median
|
7.61
|
10.16
|
11.52
|
12.12
|
--
|
Operating Efficiency
Debtors to sales
16.37
Higher than Peers by 5.75
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
16.37
|
15.42
|
14.32
|
14.95
|
--
|
|
Peer Median
|
10.62
|
7.60
|
14.45
|
9.16
|
--
|
Asset Turnover
1.37
Higher than Peers by 0.55
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
1.37
|
1.56
|
1.32
|
1.24
|
--
|
|
Peer Median
|
0.81
|
0.77
|
0.86
|
1.18
|
--
|
Receivable days
54.11
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
54.11
|
50.06
|
55.32
|
54.57
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
18.47
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
18.47
|
13.37
|
11.22
|
9.16
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
163.15
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
163.15
|
173.44
|
190.05
|
172.39
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-90.57
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
-90.57
|
-110.01
|
-123.51
|
-108.66
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
59.48
|
60.28
|
46.86
|
69.67
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
9.63
|
8.84
|
6.59
|
10.70
|
--
|
EV/EBITDA
1.72
Lower than Peers by 46.45
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
1.72
|
1.67
|
-24.34
|
2.63
|
--
|
|
Peer Median
|
48.17
|
47.88
|
27.71
|
45.91
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Modern Diagnostic & Research Centre
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
8,622
|
9,694
|
5,629
|
5,992
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
